Icahn issues new warning to board of Forest Labs

Icahn issues new warning to board of Forest Labs
Icahn maintains that Forest is at a "critical crossroads" and that the board has allowed management to rely on two products: antidepressant Lexapro, which has lost market exclusivity, and Alzheimer's drug Namenda, which is set to lose it in 2015 …

Full News here – Read more on Reuters

Leave a Reply